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ABSTRACT 
The Intracellular Transport of NSP4: A Viral Enterotoxin. (May 2014) 
 
Chinma Erika Onyewuenyi 
College of Veterinary Medicine and Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Judith M. Ball 
Department of Veterinary Pathobiology 
 
Rotaviruses are a leading cause of gastroenteritis in children worldwide. Rotavirus non-structural 
protein 4 (NSP4), a protein coded for by the viral genome, is known to play a key role in viral 
production and has been found to be able to escape the cell without being part of the virus. Being 
highly communicable, rotaviruses are transmitted fecal-orally, and in food and water. Symptoms 
accompanying disease include fever, vomiting and diarrhea, resulting in dehydration and the loss 
of electrolytes in the absence of hydrating fluids. Non-structural protein 4 (NSP4), encoded by 
the viral genome segment 10, is known to contribute to this pathogenicity as a viral enterotoxin, 
causing secretory diarrhea in the absence of histological alterations. NSP4 has recently been 
shown to traffic from the ER to the plasma membrane (PM) and to subsequently exit the cell. 
Discerning how NSP4 traffics to the PM and released is a focus of the laboratory. To date, 
several domains have been mapped to the C-terminus of NSP4. This study has begun to elucidate 
the transport domain responsible for transport of NSP4 to the PM. Using this knowledge, more 
effective therapeutics and vaccines can be developed. 
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CHAPTER I 
INTRODUCTION 
 
Rotavirus 
Rotaviruses (RV) are a major cause of life-threatening diarrhea and gastroenteritis in infants, 
young children, elderly and immunocompromised individuals. According to the Global Burden 
of Disease 2004 Update, diarrheal diseases causes approximately 17% of the 10.4 million deaths 
globally among children under five years (9). In addition, diarrheal diseases serve as the fifth 
most common cause of death in all ages and the third most common in low-income countries. In 
Africa alone, 45% of deaths in children are due to diarrheal diseases, compared to 35% in Asia 
and 20% in the remainder of the world (9).  Though rotaviruses are not the only cause of these 
diarrheal diseases, the ability to protect against rotavirus infection would result in reduction in 
the number of those infected and subsequent disease symptoms. As of now, only two vaccines 
are approved for worldwide usage, Rotatrix ® and RotaTeq ®, despite their limited efficacy 
against new viral strains and the possibility of intussusception (20). Further study of rotavirus is 
imperative in creating better vaccines and therapeutics for protection of children in the United 
States and worldwide. 
 
Rotavirus belongs to the family Reoviridae, and contains 11 double-stranded RNA (dsRNA) 
segments enclosed in a triple-layered, concentrically arranged capsid coat with outer protein 
spikes. This triple-layer protein coat comprises the infectious viral particle and is believed to 
stabilize the virus, which allows for fecal-oral transmission from person to person, through 
water, or through inadequately heated food. The RV genome codes for six structural proteins 
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(VP) and six non-structural proteins (NSP); the core of the virus holds NSP3, which aids in 
mRNA circularization, NSP2, a helicase, NSP5, a phosphoprotein with kinase activity, NSP1, a 
RNA binding protein, and NSP6, a protein that binds to NSP5 (7, 12).  The inner core is 
composed of 60 dimers of VP2, a protein required for replicase activity, which encases VP1, a 
RNA-dependent polymerase and VP3, a guanylyltransferase and methyltransferase (7, 12). The 
middle protein layer is composed of 60 dimers of VP6 while the outer protein layer consists of 
260 trimers of VP7. The 60 intermittent spikes penetrate the outer protein coat and are composed 
of asymmetric dimers of VP4 (7, 12).  The main domains of the spikes lie in the innermost layer, 
continue through the middle layer and protrude just above the outer layer. These spikes bind to 
receptors on the cell surface and allow for attachment of the viral particle to the cell. The spikes 
undergo enzymatic cleavage to produce VP5* and VP8* which aid in receptor recognition, thus 
increasing infectivity in some rotavirus strains (4, 12).  
 
The virus is able to enter the cell by initially attaching to outer membrane molecules via the VP4 
spikes on the capsid coat. The virus then, is able to be brought into the cell where it loses its 
calcium-dependent VP7 outer layer creating a double-layered particle (DLP). A conformational 
change in the DLP opens 12 aqueous channels that allow for nucleotides and hydrolysable ATP 
to enter the DLP core while newly synthesized 5’-capped, but not polyadenylated, RNA strands 
leave the core (18). Viroplasms, or “virus factories”, containing VP2, NSP2, NSP5, and NSP6, 
and other viral proteins form adjacent to the endoplasmic reticulum (ER)  (10, 17). There, DLPs 
are assembled with viral proteins and dsRNA segments (8). NSP4, originally classified as a 
resident ER protein, aids in the DLP’s budding into the calcium rich environment of the ER 
lumen by binding to VP6 (1). Once inside the ER lumen, the DLP acquires transient lipid 
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membrane and VP7 is assembled to form the TLP (1). Whether the VP4 spikes are added in the 
lumen with VP7 or at the plasma membrane before the virion leaves the cell remains unclear. 
 
NSP4  
NSP4 is a key protein in the morphogenesis and pathogenesis of RV. It contains 175 amino 
acids, with one transmembrane domain, 2 N-terminal hydrophobic domains, 2 N-terminal, N-
linked glycosylation sites and protein binding domains in the extended cytoplasmic C-terminus 
region (1, 2).  
 
 
Figure 1. NSP4 structure and binding sites (Taken from Parr, et al., ref. (15)) 
 
NSP4’s main purpose is to function as an intracellular viral receptor and aid in the 
morphogenesis and maturation of the viral particle. Residing in the ER membrane, NSP4 
mediates the budding of the DLP into the ER by attaching to the VP6 outer layer of the DLP on 
the cytosolic side of the reticulum. In this way, NSP4 plays a regulatory role in the maturation 
process of the viral particle. Experiments in which NSP4 was silenced resulted in a 75-80% 
reduction in the amount of infectious progeny, a notable accumulation of empty viral particles, 
an intracellular redistribution of viral proteins, and in increase in viral RNA transcription (5, 13, 
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19). These results indicate NSP4 plays an active role in replication and morphogenesis. 
Furthermore, proteins commonly found in the viroplasm were dispersed throughout the 
cytoplasm.  
 
NSP4 is known to interact with intracellular host cell proteins such as caveolin-1 (Cav-1), 
cyclophilin A (CypA), cyclophilin 40 (Cyp40), heat shock protein 56 (HSP56) and many other 
host cell and viral proteins (3, 14, 15, 22, 23). These interactions provide a possible explanation 
for NSP4 transport through the cell to the plasma membrane by an unconventional mechanism. 
We have shown that NSP4 remains sensitive to endoglycosidase H, an enzyme used by the golgi 
apparatus to modify proteins destined to leave the cell, and thus, does not go through 
oligosaccharide processing in the golgi before leaving the cell (2, 6, 21). Therefore, we predict 
NSP4 reaches the plasma membrane and exits the cell by more than one mechanism. 
 
NSP4 also plays a role as a viral enterotoxin, contributing to the pathogenicity of the virus.  
Enterotoxins are defined as toxins that stimulate net secretion in ligated segments in the absence 
of histological alteration and/ or promote secretory currents as measured in Ussing chambers (1). 
In an experiment involving NSP4, the protein alone causes age-dependent diarrhea in mice by 
promoting chloride secretory currents in intestinal mucosa cells, without alterations of the 
histological compositions of the cells (1). Therefore, it is also necessary to evaluate the 
intracellular transport mechanism of NSP4 to better understand how to generate effective 
treatments for its enterotoxic activity. 
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We have previously found that NSP4 interacts with a complex known to transport cholesterol 
from the ER to the PM, called the caveolin chaperone complex (CCC). The objective of this 
project is to map the domain of NSP4 responsible for its interactions with the CCC. Entry 
vectors using the pCR®8/GW/TOPO® (Invitrogen) backbone were constructed using several 
NSP4 truncations. The LR Clonase enzyme was then used to transfer the truncations into the 
destination vector plasmid, pcDNA6.2™/V5-DEST by recombination using att sites. The 
resulting NSP4 truncations contained a V5 tag on the C-terminal end for easy detection of 
fragments. HT29.f8 and MA104 cell lines were then transfected with the plasmid using 
transfection reagents. Immunoprecipitations were performed using magnetic DynaBeads 
conjugated to antibodies against the proteins of the CCC. The precipitated proteins were 
dissociated from the beads and separated by SDS-PAGE followed by a Western blot on to a 
nitrocellulose membrane. An anti-V5 antibody was used to detect immunoprecipitated NSP4. 
Once it is clear which domain associates with the CCC components, we will determine how 
transport is affected when the interaction of the CCC components and NSP4 is ablated using 
confocal microscopy and surface biotinylation.  
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CHAPTER II 
METHODS 
 
Oligonucleotide Design 
PCR primers were designed to amplify truncations of NSP4 from RV strain SA11.4f using the 
TA TOPO Cloning method (Life Technologies, Grand Island, NY). Briefly, forward and reverse 
oligonucleotides were designed to amplify portions of NSP4 with a single A overhangs, and 
nucleotides were added to ensure that NSP4 was inserted in-frame with the V5 tag in the 
destination vector, pcDNA6.2™/V5-DEST. The oligonucleotides used are listed in Table 1 and 
were ordered from Integrated DNA Technologies (Coralville, IA).  
 
Table 1. Primer sequences and corresponding names for NSP4 constructions 
Primer Order Primer Name Primer Sequence 
Forward from 1 CO4 accatggaaaagcttaccgac 
Forward from 138 CO6 accatgctacataaagcatccattcc 
Forward from 241 CO7 accatgaaattggcaggttataaagag 
Forward from 270 CO8 accatgactaaagatgagatagaaaagc 
Forward from 304 CO9 accatggtagtcaaagaaatgagac 
Forward from 336 CO10 accatgattgacaaattgactacacg 
Reverse from 150 CO13 ggaatggatgctttatgtag 
Reverse from 270 CO14 agttatctgctctttataacctgcc 
Reverse from 321 CO11 tctcatttctttgactactctgtccat 
Reverse from 420 CO12 gcctgtcgtttgcaccg 
Reverse from 525 CO5 cattgctgcagtcacttctcttg 
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Media and Reagents 
Luria Broth media was prepared for growth of DH5α E. coli; 10 g of Bacto-tryptone, 5 g of yeast 
extract, and 5 g of NaCl were added per liter of autoclaved distilled water and the pH of the 
solution was adjusted to 7.0. To prepare plates, 15 g of Bacto-agar were added. A spectinomycin 
stock was prepared by adding 50 mg of spectinomycin dihydrochloridepentahydrate to 5 ml of 
distilled water (10mg/ml). The solution was then sterile filtered and aliquoted into 0.5 ml 
portions in Eppendorf tubes and stored at -20°C. Carbenicillin stocks were prepared by 
dissolving 1 g carbenicillin (GoldBio, St. Louis, MO) in 10 ml milli-Q dH2O (100mg/ml). The 
solution was sterile filtered, aliquoted, and stored as above. 
 
Polymerase Chain Reaction 
PCR was performed to amplify NSP4 truncations with TA overhangs using MyTaq DNA 
Polymerase (Bioline, Taunton, MA). The vector pENTR11-FLNSP4 served as the template for 
the truncation constructions, which contains the entire RV SA11.4f NSP4 sequence. The 
appropriate forward and reverse primers were used according to the following table: 
 
 Table 2. Forward and reverse primers used in tubes for experiment. 
Tube 
Order 
Forward 
Primer 
Reverse 
Primer 
Tube 1-525 CO4 CO5 
Tube 1-420 CO4 CO12 
Tube 1-321 CO4 CO11 
Tube 1-270 CO4 CO14 
Tube 1-150 CO4 CO13 
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Taq polymerase, which catalyzes the addition of the nucleotides to the expanding chains and 
dNTP mix, which provides the necessary nucleotides, were added to each tube. The cycling 
parameters were set up as following: 
 
Table 3. PCR cycling parameters used 
Stages: Temperature: Time: 
Stage 1 95°  2 minutes 
Stage 2 95°  15 seconds 
52°  15 seconds 
72°  10 seconds 
Stage 3 72°  10 minutes 
Hold 4°  Hold 
 
The PCR enzymes were removed using the UltraClean PCR Cleanup Kit (Mo Bio Laboratories, 
Carlsbad, CA) following manufacturer’s instructions. The reaction products were run on a 1% 
agarose gel to verify the correct PCR fragments were constructed. 
 
The PCR fragments were cloned into the pCR®8/GW/TOPO® vector using the 
pCR®8/GW/TOPO® TA Cloning® Kit (Life Technologies) according to manufacturer’s 
instructions. The resulting products were transformed into DH5α E. coli as described below and 
plated on LB media plates with 40 µg/mL carbenicillin (GoldBio).  
 
E. Coli Transformation and Expansion 
Plasmids and E. coli strains were thawed on ice for 15 min. Plasmids (1 µg) were gently mixed 
with E. coli and incubated for 15 min on ice. The E. coli were heat shocked for 45 sec at 42°C 
and incubated at R.T. for 5 min. 250 µL of warm Super Optimal Broth with Catabolite 
Repression (SOC) media was added to each tube and tubes were shaken at 250 rpm for 1 h at 
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37°C. E. coli was plated on agar plates with LB and incubated overnight at 37°C. Individual 
colonies were picked and placed into 5 ml LB media with selection antibiotics and shaken at 250 
rpm for 12-16 hours. If further expansion was necessary, 2 ml of overnight culture was added to 
100 ml of LB media with selection antibiotics and shaken at 250 rpm until the O.D. 600 reached 
1.  
 
Plasmid Isolation 
Plasmids were isolated with the Fermentas GeneJet Miniprep Kit (Fisher Scientific, Pittsburg, 
PA) or the Promega Wizard Maxiprep Kit (Promega, Madison, WI) per manufacturer’s 
instructions. Briefly, tubes containing expanded E. Coli were centrifuged at 3000 rpm for 10 min 
and the supernatant discarded. The pellets were resuspended in proprietary Resuspension buffer. 
Lysis solution was added and the tubes mixed by inversion 6 times. Neutralization solution was 
added and the tubes inverted 6 times and centrifuged at 12,000 rpm for 2 min. The supernatant 
was transferred to a GeneJet spin column and centrifuged at 12,000 rpm for one minute and the 
flow through discarded to a waste container. The Wash solution was added to each filter and 
centrifuged at 12,000 rpm 1 min. The flow through was discarded and each tube centrifuged for 
2 min to dry. The spin columns were transferred to a clean Eppendorf tube and Elution buffer 
was added. The tubes were incubated at room temperature and centrifuged for two minutes to 
collect the resulting plasmid DNA and was stored at -20°C. 
 
LR Clonase Reaction 
The NSP4 gene was transferred from the pCR®8/GW/TOPO® to the destination vector, 
pcDNA6.2™/V5-DEST (Life Technologies) using the LR Clonase II reaction (Life 
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Technologies). Briefly, the pCR®8/GW/TOPO® vector containing an NSP4 truncation, the 
pcDNA6.2™/V5 destination vector, 1X TE buffer and LR Clonase II were added to a 
microcentrifuge tube. The mixture was incubated at room temperature (25°C) for 1 hour. One 
microliter of Proteinase K solution was added to each sample, the samples were vortexed briefly, 
and then incubated for 10 minutes in the 37°C water bath.  One microliter of each reaction was 
transformed into DH5α E. coli as described above. 
 
Restriction Enzyme Digestion 
Restriction enzyme digestions were performed with Fast Digest Restriction Enzymes 
(Fermentas) on pcDNA6.2™/V5-DEST plasmids containing NSP4 by mixing 0.5-1 µg of 
plasmid with 5X Green Buffer, DNAse-free water and the necessary restriction enzymes. The 
samples were incubated at 37°C in a water bath for fifteen minutes. A 1% agarose gel was made 
by adding 1 g of High Melt Agar (CLP, Oakland, California) to 100 mL of TAE Buffer and 
heating for 2 minutes in a microwave with intermittent stirring. The samples were mixed with 6X 
loading buffer and added to the cooled 1% agarose gel containing Ethidium Bromide (10 
ug/mL). The gel was run at 150 volts and the bands were detected using the AlphaImager® gel 
imaging machine under UV light.  
 
Transfection of Mammalian Cells with pcDNA6.2/V5-DEST-NSP4 Fragments 
MA104 and HT29.f8 cells were grown in a 48-well plate to 90% confluency. Briefly, 
Lipofectamine (Life Technologies) or plasmid DNA was added to serum-free DMEM and 
equilibrated for ten minutes at 25°C Media containing the Lipofectamine and the plasmid DNA 
were mixed together and incubated for 5 min. The plasmid-Lipofectamine mixture was added to 
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the wells containing cells and incubated at 37°C for 4 hours to allow for uptake of the plasmid 
DNA. Serum was added to the cells and the cells were incubated for 44 more hours at 37°C. 
Transfection was verified by epifluorescence using the control plasmid pEGFP-C2, which 
expresses GFP. 
 
Co-Immunoprecipitation 
Dynabeads® (Life Technologies) coated with Protein G were prepared by aliquotting into 
microcentrifuge tubes, removing the storage buffer, and resuspending in PBS. The tube was 
placed on a magnet in order to separate the beads from solution and the supernatant removed. 
The antibody to be conjugated to the beads was diluted in PBS with 0.05% Tween-20 and added 
to the beads. The tube was incubated at room temperature with rotation for 10 minutes to allow 
for binding of the antibody to Protein G. The tube was placed on the magnet then the supernatant 
removed. The beads with attached antibodies (Ab) were washed by resuspending in PBS with 
0.05% Tween-20 and pipetting gently. The tube was placed on the magnet and the supernatant 
removed once again. The cell lysates were added to the tube and the Dynabeads-Ab complex 
resuspended by pipetting. The tubes were incubated overnight at 4°C with rotation. The tubes 
were placed on the magnet and the supernatant saved for further analysis. The Dynabeads-Ab-Ag 
complex was washed three times with Washing Buffer and the supernatant discarded.  
 
Polyacrylamide Gel Electrophoresis 
To prepare an acrylamide gel, 12.5% NEXT GEL® (Amresco, Solon, OH), 10% ammonium 
persulphate (w/v) (APS), and TEMED were combined in a small beaker and mixed well. The gel 
apparatus was set up and the mixture added until it polymerized. The gels were placed in the gel 
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running apparatus and 1X NEXT GEL Running Buffer was added and the solution poured over 
the entire apparatus. Samples were individually loaded in the wells and the gel was run at 120V 
for 2 hours to separate the proteins. 
 
Western Blot 
The polyacrylamide gel was removed from the gel running apparatus and sandwiched between 
two filter papers and two foam pads next to a nitrocellulose membrane. The sandwich was placed 
into the blot apparatus and run at 300 mA for 2 hours at 4°C. The blot was blocked with 10% 
milk in PBS for 1 hour and incubated with antibodies overnight at 4°C. The blot was washed 
with PBS, PBS Tween-20, and PBS again. Secondary antibody was added and incubated for 1 
hour. The blot was washed and detected using chemiluminescent substrate (Millipore, Billerica, 
MA). The chemiluminescence was captured on a film and developed. 
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CHAPTER III 
RESULTS 	  
Truncations of NSP4 Cloned Into pCR®8/GW/TOPO® Backbone 
NSP4 truncations were amplified with Taq Polymerase to produce A overhangs on the 3’ ends 
according to Table 2. The correct fragments were identified by resolution on a 2% agarose gel.  
The PCR fragments were inserted into the pCR®8/GW/TOPO® backbone using the TA-TOPO 
Cloning Kit. Restriction enzyme digestion with XhoI and EcoRI indicated the correct fragments 
were incorporated into the plasmid prior to continuing with the next step as shown in Figure 2.  
The staggered pattern and migration to the correct molecular weights indicate that the correct 
fragments were generated. Markers (DNA Hind III) are shown on the left.  
 
 
 
 
 
 
Figure 2. NSP4 PCR products (1-150, 1-270, 1-325, 1-420) 
 
NSP4 Truncations Were Transferred From Entry Vector to Destination Vector 
Using vectors from the Gateway system by Invitrogen, the NSP4 truncations were transferred 
from the pCR®8/GW/TOPO® entry vector to the pcDNA6.2™/V5-DEST destination vector 
using LR Clonase II. The vector maps of the pCR®8/GW/TOPO® and pcDNA6.2™/V5-DEST 
are shown in Figure 3. 
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Figure 3a.  Diagram of pCR®8/GW/TOPO® vector backbone showing Spectinomycin resistance 
gene and attL sites used in LR Clonase II reaction. 
 
 
 Figure 3b. Diagram of pcDNA6.2™/V5-DEST vector backbone showing Ampicillin resistance 
gene and attR sites used in LR Clonase II reaction 
 
The plasmids are resistant to either spectinomycin or ampicillin, respectively, and empty vectors 
contain a ccdB gene.  Recombination with the LR Clonase II transfers the fragment from the 
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TOPO vector to the pcDNA6.2™/V5-DEST vector.  The products were transformed into E. coli 
and growth was monitored.  The bacteria grew indicating they contained the carbenicillin 
resistance gene and that the transformation was successful with the pcDNA6.2™/V5-DEST 
vector containing the NSP4 truncations. 
 
Plasmids were isolated and subjected to restriction endonucleases digestion to verify the correct 
constructs were incorporated into the vectors.   NdeI, ApaI or BglII were used for restriction 
enzyme digestion. The resulting gel verified the correct plasmid was isolated and contained the 
appropriate truncations. To further verify that the plasmids contained the correct NSP4 
truncation they were sequenced using forward and reverse primers mentioned in the methods 
section. 
 
Transfected Mammalian Cells Express NSP4 Truncations With V5 tag 
Transfection parameters for MA104 and HT29.f8 cells were determined using the pEGFP-12.2-
DEST plasmid with MDCK and HT29.f8 cell lines.  Intracellular fluorescence using epi-
fluorescence microscopy indicated a successful transfection (Figure 5). This experiment 
revealed that Lipofectamine 2000 and PolyPlus JetPrime® produced the best transfection results 
in MDCK and HT29.f8 cells, respectively. Following these parameters, MA104 cells (in lieu of 
MDCK cells) and HT29.f8 cells were transfected with the pcDNA6.2™/V5-DEST plasmids 
containing the NSP4 truncations. The cells were incubated for 48 h, lysed and subjected to SDS-
PAGE and Western blot. Detection with an antibody targeting the V5 tag showed that protein 
expression occurred at 48 h post transfection (hpt). However, HT29.f8 cells transfected with the 
plasmid containing NSP4138-525 was toxic to the cells, and caused significant CPE at 48 hpt. 
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Figure 5a. Epi-fluorescence of MDCK cells transfected with pDEST-12.2 expressing a GFP tag. 
 
 
Figure 5b. Epi-fluorescence of HT-29.f8 cells transfected with pDEST-12.2 expressing a GFP 
tag. 
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Immunoprecipitation of NSP4 Truncations Using Antibodies Directed Against the V5-
Epitope Tag 
To map the binding domain of the CCC proteins, antibodies directed against the V5 tag were 
coupled to the Dynabeads® for co-immunoprecipitations.   Cells were transfected with plasmids 
containing either full-length or the NSP4 truncations, lysed, and subjected to SDS-PAGE and 
silver stain or Western blot. The silver stain showed the monomeric and dimeric forms of full-
length NSP4 in addition to higher molecular weight proteins that co-immunoprecipitated with the 
V5 tag (Figure 6).  
 
Figure 6. Silver stain showing the monomeric and dimeric forms of full length NSP4 
 
To further verify that the proteins were indeed NSP4, a western blot was performed using a rat 
antibody directed against the C-terminus of NSP4. Using an antibody generated in rats allowed 
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us to avoid cross reactivity with the antibody generated in rabbits used for the pull down assay. 
The developed film shows the monomeric and dimeric forms of NSP4 were immunoprecipitated, 
verifying that the bands are full-length NSP4 (Figure 6).  
 
 
Figure 7. Western blot showing monomeric and dimeric forms of NSP4 of full length NSP4 
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CHAPTER IV 
DISCUSSION 
 
To prepare the NSP4 truncations, seven plasmids containing a NSP4 truncation mutant and 
lacking a stop codon were generated and verified by RE digestion and sequencing. The 
truncations were cloned into the pCR®8/GW/TOPO® entry vector using TA TOPO® cloning. The 
inserts were transferred to the pcDNA6.2™/V5-DEST entry vector backbone containing the V5 
epitope at the C-terminus. Using liposome-mediated transfection, the plasmids were transfected 
into both HT29.f8 and MA104 mammalian cells.  NSP4-V5 truncations were expressed and 
immunoprecipitated.  Additional experiments are now ready to be completed.  
 
At this point, we have shown that the constructs have been made and full length NSP4 can be 
transfected into mammalian cells and immunoprecipitated with a V5 tag antibody. The next step 
is to verify expression of the correct NSP4 deletion mutants by western blot. After verification of 
the correct truncation, immunoprecipitations and surface biotinylations will be performed with 
the truncated NSP4 to determine if NSP4 is associating with the soluble CCC and whether it is 
reaching the PM. Once the transport domain has been delineated, then small molecules can be 
designed to block transport of NSP4 out of the cell. By blocking this domain, secretory diarrhea 
would be prevented, alleviating the severity of symptoms associated with RV infection.  
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